Skip to main content Accessibility help
  • Online publication date: March 2015

Chapter 26 - Non-neoplastic diseases of the small and large intestines


1. Whitehead R. Normal appearances in small intestine biopsy specimens. In: Whitehead R, ed. Mucosal Biopsy of the Gastrointestinal Tract, Major Problems in Pathology Series, vol. 3, 5th edn. Philadelphia, PA: WB Saunders; 1997: pp. 175–184.
2. Hart J, Lewin KJ, Peters RS, Schwabe AD. Effect of long-term colchicine therapy on jejunal morphology. Dig Dis Sci 1993; 38: 2017–2021.
3. Goldman H, Antonioli DA. Mucosal biopsy of the rectum, colon, and distal ileum. Hum Pathol 1982; 13: 981–1012.
4. Lala S, Ogura Y, Osborne C, et al. Crohn’s disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 2003; 125: 47–57.
5. Grimm MC, Pavli P. NOD2 mutations and Crohn’s disease: are Paneth cells and their antimicrobial peptides the link? Gut 2004; 53: 1558–1560.
6. Veress B, Franzén L, Bodin L, Borch K. Duodenal intra-epithelial lymphocyte count revisited. Scand J Gastroenterol 2004; 39: 138–144.
7. Lowichik A, Weinberg AG. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol 1996; 9: 110–114.
8. Strobel S, Miller HR, Ferguson A. Human intestinal mucosal mast cells: evaluation of fixative and staining techniques. J Clin Pathol 1981; 34: 851–858.
9. Strobel S, Busuttil A, Ferguson A. Human intestinal mucosal mast cells: expanded population in untreated celiac disease. Gut 1983; 24: 222–227.
10. Landboe-Christensen E. The duodenal glands of Brunner in man, their distribution and quantity. Acta Pathol Microbio Scand 1944; 52(Suppl): 240.
11. Shamsuddin A, Phelps PC, Trump BF. Human large intestinal epithelium: light microscopy, histochemistry, and ultrastructure. Hum Pathol 1982; 13: 790–803.
12. Levine DS, Haggitt RC. Normal histology of the colon. Am J Surg Pathol 1989; 13: 966–984.
13. Goldman H. Interpretation of large intestinal mucosal biopsy specimens. Hum Pathol 1994; 25: 1150–1159.
14. Tanaka M, Saito H, Kusumi T, et al. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease. J Gastroenterol Hepatol 2001; 16: 1353–1359.
15. Goldstein NS, Bhanot P. Paucicellular and asymptomatic lymphocytic colitis. Expanding the clinicopathologic spectrum of lymphocytic colitis. Am J Clin Pathol 2004; 122: 405–411.
16. Pascal RR, Gramlich TL, Parker KM, Gansler TS. Geographic variations in eosinophil concentration in normal colonic mucosa. Mod Pathol 1997; 10: 363–365.
17. Janatuinen EK, Pikkarainen PH, Kemppainen TA, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333: 1033–1037.
18. Green PHR, Jabri B. Coeliac disease. Lancet 2003; 362: 383–391.
19. Lowichik A, Book L. Pediatric celiac disease: clinicopathologic and genetic aspects. Pediatr Devel Pathol 2003; 6: 47–83.
20. Brady CE. Occult celiac sprue masquerading as severe iron deficiency anemia. J Clin Gastroenterol 1994; 18: 130–132.
21. Kepczyk T, Kadakia SC. Prospective evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. Dig Dis Sci 1995; 40: 1283–1289.
22. Grodzinsky E. IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy 1994; 49: 593–597.
23. Pacht A, Sinai N, Hornstein L, et al. The diagnostic reliability of the anti-endomysial antibody in celiac disease: the north Israel experience. Israel J Med Sci 1995; 31: 218–220.
24. Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Ström M. Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? Dig Dis Sci 1996; 41: 83–87.
25. Cunningham-Rundles C. Selective IgA deficiency and the gastrointestinal tract. Immunol Allerg Clin North Am 1988; 8: 435–449.
26. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen in celiac disease. Nature Med 1997; 3: 797–801.
27. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunoabsorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322–1328.
28. Sblattero D, Berti I, Trevisiol C, et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000; 95: 1253–1257.
29. Scoglio R, Di Pasquale G, Pagano G, et al. Is intestinal biopsy always needed for diagnosis of celiac disease? Am J Gastroenterol 2003; 98: 1325–1331.
30. Castano L, Blarduni E, Ortiz L, et al. Prospective population screening for celiac disease: high prevalence in the first 3 years of life. J Pediatr Gastroenterol Nutr 2004; 39: 80–84.
31. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330–354.
32. Marsh MN. The natural history of gluten sensitivity: defining, refining, and re-defining. Q J Med 1995; 85: 9–13.
33. Freedman A, Macartney JC, Nelufer JM, Ciclitira PJ. Timing of the infiltration of T lymphocytes induced by gluten into the small intestine of coeliac disease. J Clin Pathol 1987; 40: 741–745.
34. Ferguson A, Blackwell JN, Barnetson RS. Effect of additional dietary gluten on the small-intestinal mucosa of volunteers and of patients with dermatitis herpetiformis. Scand J Gastroenterol 1987; 22: 543–549.
35. Picarelli A, Maiuri L, Mazzilli MC, et al. Gluten-sensitive disease with mild enteropathy. Gastroenterology 1996; 111: 608–616.
36. Scott BB, Losowsky MS. Patchiness and duodenal–jejunal variation of the mucosal abnormality in celiac disease and dermatitis herpetiformis. Gut 1976; 17: 984–992.
37. Trier JS. Diagnosis of celiac disease. Gastroenterology 1998; 115: 211–216.
38. Goldstein NS. Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac disease. Am J Clin Pathol 2004; 121: 546–555.
39. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012; 87: 732–738.
40. Mino M, Lauwers, G. Role of lymphocytic immunophenotyping in the diagnosis of gluten-sensitive enteropathy with preserved villous architecture. Am J Surg Pathol 2003; 27: 1237–1242.
41. Goldstein NS, Underhill J. Morphologic features suggestive of gluten sensitivity in architecturally abnormal duodenal biopsies. Am J Clin Pathol 2001; 116: 63–71.
42. Goldstein NS. Proximal small bowel mucosal villous intraepithelial lymphocytes. Histopathology 2004; 44: 199–205.
43. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 2000; 356: 203–208.
44. Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998; 114: 471–481.
45. Patey-Mariaud de Serre, N, Cellier C, Jabri B, et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology 2000; 37: 70–77.
46. Weinstein WM, Saunders DR, Tytgat GN, Rubin CE. Collagenous sprue: an unrecognized type of malabsorption. N Engl J Med 1970; 283; 1297–1301.
47. Zeman RK, Toffler RB. Collagenous sprue. Am J Gastroenterol 1978; 70: 541–544.
48. Murray A, Cuevas EC, Jones DB, Wright DH. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 1995; 146: 509–519.
49. Epstein A. Weekly clinicopathological exercises. Case 15-1996: Celiac disease and T-cell lymphoma. N Engl J Med 1996; 334: 1316–1322.
50. Collin P, Reunala T, Pukkala E, et al. Coeliac disease – associated disorders and survival. Gut 1994; 35: 1215–1218.
51. Wolber R, Owen D, Freeman H. Colonic lymphocytosis in patients with celiac sprue. Hum Pathol 1990; 21: 1092–1096.
52. Fine KD, Meyer RL, Lee EL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997; 112: 1830–1838.
53. Rosen FS, Cooper MD, Wedgwood RJP. The primary immunodeficiencies. N Engl J Med 1995; 333: 431–440.
54. Luzi G, Zullo A, Iebba F, et al. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol 2003; 98: 118–121.
55. Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Reports 2004; 6: 377–383.
56. Sander CA, Medeiros LJ, Weiss LM, et al. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 1992; 16: 1170–1182.
57. Sherman PM, Mitchell DJ, Cutz E. Neonatal enteropathies: defining the causes of protracted diarrhea of infancy. J Pediatr Gastroenterol Nutr 2004; 38: 16–26.
58. Corrazza G, Biagi F, Volta U, et al. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997; 350: 106–109.
59. Hori K, Fukuda Y, Tomita T, et al. Intestinal goblet cell autoantibody associated enteropathy. J Clin Pathol 2003; 56: 629–630.
60. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990; 31: 54–58.
61. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004; 113: 11–28.
62. Jensen RT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am 2000; 14(3): 579–623.
63. Abramowsky C, Hupertz V, Kilbridge P, Czinn S. Intestinal lymphangiectasia in children: a study of upper gastrointestinal endoscopic biopsies. Pediatr Pathol 1989; 9: 289–297.
64. Fox U, Lucani G. Disorders of the intestinal mesenteric lymphatic system. Lymphology 1993; 26: 61–66.
65. de Souza JS, da Silva A, Pereira MV, Soares J, Magalhães Ramalho P. Cow’s milk protein-sensitive enteropathy: number and timing of biopsies for diagnosis. J Pediatr Gastroenterol Nutr 1986; 5 207–209.
66. Perkkio M, Savilahti E, Kuitunen P. Morphometric and immunohistochemical study of jejunal biopsies from children with intestinal soy allergy. Eur J Pediatr 1981; 137: 63–69.
67. Phillips AD, Jenkins P, Raafat F, Walker-Smith JA. Congenital microvillous atrophy: specific diagnostic features. Arch Dis Childhood 1985; 60: 135–140.
68. Phillips A, Fransen J, Hauri HP, Sterchi E. The constitutive exocytotic pathway in microvillous atrophy. J Pediatr Gastroenterol Nutr 1993; 17: 239–246.
69. Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 2001; 13: 533–538.
70. Wetterau JR, Aggerbeck LP, Bouma ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992; 258: 999–1001.
71. Rader DJ, Brewer HB. Abetalipoproteinemia – new insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disorder. JAMA 1993; 270: 856–859.
72. Adelson JW. Weekly clinicopathological exercises. Case 35-1992: abetalipoproteinemia. N Engl J Med 1992; 327: 625–635.
73. Schreiber D, Blacklow NR, Trier JS. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med 1973; 288: 1318–1323.
74. Oberhuber G, Stolte M. Giardiasis: analysis of histological changes in biopsy specimens of 80 patients. J Clin Pathol 1990; 43: 641–643.
75. Trier JS. Tropical sprue (weekly clinicopathological exercises). N Engl J Med 1990; 322: 1067–1075.
76. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 1992; 327: 293–301.
77. Keinath RD, Merrell DE, Vlietstra R, Dobbins WO III. Antibiotic treatment and relapse in Whipple’s disease. Gastroenterology 1985; 88: 1867–1873.
78. Schwartz DA, Sobottka I, Leitch GJ, Cali A, Visvesvara GS. Pathology of microsporidiosis: emerging parasitic infections in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1996; 120: 173–188.
79. da Silva AJ, Schwartz DA, Visvesvara GS, et al. Sensitive PCR diagnosis of Enterocytozoon bieneusi (microspordia) using primers based on the region coding for small-subunit rRNA. J Clin Microbiol 1996; 34: 986–987.
80. Whitehead R. The pathology of intestinal ischemia. Clin Gastroenterol 1972; 1: 613–637.
81. Whitehead R. The pathology of ischemia of the intestine. In: Sommers SC, ed. Pathology Annual. Norwalk, CT: Appleton-Century-Crofts; 1976: pp. 1–52.
82. Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesions in low flow states. I. A morphological, hemaodynamic, and metabolic reappraisal. Arch Surg 1970; 101: 478.
83. Dignan CR, Greenson JH. Can ischemic colitis be differentiated from C. difficile colitis in biopsy specimens? Am J Surg Pathol 1997; 21: 706–710.
84. Deana DG, Dean PJ. Reversible ischemic colitis in young women. Association with oral contraceptive use. Am J Surg Pathol 1995; 19: 454–462.
85. Hamed RM, Ghandour K. Abdominal angina and intestinal gangrene – a catastrophic presentation of arterial fibromuscular dysplasia: case report and review of the literature. J Pediatr Surg 1997; 32: 1379–1380.
86. Niazi M, Kondru A, Levy J, Bloom AA. Spectrum of ischemic colitis in cocaine users. Dig Dis Sci 1997; 42: 1537–1541.
87. Linder JD, Mönkemüller KE, Raijman I, et al. Cocaine-associated ischemic colitis. South Med J 2000; 93: 909–913.
88. Feldman PS. Ulcerative disease of the colon proximal to partially obstructive lesions: report of two cases and review of the literature. Dis Colon Rectum 1975; 18: 601–612.
89. Wolloch Y, Zer M, Lurie M, et al. Ischemic colitis proximal to obstructing carcinoma of the colon. Am J Proct Gastroenterol Colon Rectal Surg 1979; 328–335.
90. Griffin PM, Olmstead LC, Petras RE. Escherichia coli O157:H7-associated colitis. A clinical and histologic study of 11 cases. Gastroenterology 1990; 99: 142–149.
91. Kelly JK, Pai CH, Jadusingh IH, et al. The histopathology of rectosigmoid biopsies from adults with bloody diarrhea due to verotoxin-producing Escherichia coli. Am J Clin Pathol 1987; 88: 78–82.
92. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic–uremic syndrome. N Engl J Med 1995; 333: 354–368.
93. Siegler RL, Pravia AT, Christofferson RD, et al. A 20-year population-based study of post-diarrheal hemolytic–uremic syndrome in Utah. Pediatrics 1994; 94: 35–40.
94. Bender JB, Hedberg CW, Besser JM, et al. Surveillance by molecular subtype for E. coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 1997; 337: 388–394.
95. Dhillon AP, Anthony A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992; 21: 127–133.
96. Kelly J, Oryshak A, Wenetsek M, et al. The colonic pathology of Escherichia coli O157:H7 infection. Am J Surg Pathol 1990; 14: 87–92.
97. Jeanette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthrit Rheum 1994; 37: 187–192.
98. Muller-Ladner U. Vasculitides of the gastrointestinal tract. Best Practice Res Clin Gastroenterol 2001; 15: 59–82.
99. Frankel SK, Sullivan EJ, Brown KK. Vasculitis: Wegener’s granulomatosis, Churg–Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis. Crit Care Clin 2002; 18: 1–24.
100. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277–301.
101. Solans R, Bosch JA, Pérez-Bocanegra C, et al. Churg–Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology 2001; 40: 763–771.
102. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg–Strauss syndrome. Lancet 1998; 7: 238–258.
103. Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthrit Rheumat 2003; 49: 709–715.
104. Storesund B, Gran JT, Koldingsnes W. Severe intestinal involvement in Wegener’s granulomatosis: report of two cases and review of the literature. Br J Rheumatol 1998; 37: 387–390.
105. Burke AP, Sobin LH, Virmani R. Localized vasculitis of the gastrointestinal tract. Am J Surg Pathol 1995; 19: 338–349.
106. Hallegua DS, Wallace DJ. Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol 2000; 12: 379–385.
107. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology 1999; 38: 917–932.
108. Marshall SE. Behçet’s disease. Best Pract Res Clin Rheumatol 2004; 18: 291–311.
109. Chang WL, Yang YH, Lin YT, Chiang BL. Gastrointestinal manifestations in Henoch–Schönlein purpura: a review of 261 patients. Acta Paediatr 2004; 93: 1427–1431.
110. Saraga E, Bouzourenne H. Enterocolic lymphocytic phlebitis: a rare cause of intestinal ischemic necrosis. Series of patients and review of the literature. Am J Surg Pathol 2000; 24: 824–829.
111. Flaherty MJ, Lie JT, Haggitt RC. Mesenteric inflammatory veno-occlusive disease. A seldom recognized cause of intestinal ischemia. Am J Surg Pathol 1994; 18: 779–784.
112. Saul SH, Sollenberger LC. Solitary rectal ulcer syndrome: its clinical and pathological underdiagnosis. Am J Surg Pathol 1985; 9: 411.
113. Levine DS. ‘Solitary’ rectal ulcer syndrome. Are ‘solitary’ rectal ulcer syndrome and localized colitis cystica profunda analogous syndromes caused by rectal prolapse? Gastroenterology 1987; 92: 243–253.
114. Li SC, Hamilton SR. Malignant tumors in the rectum simulating solitary rectal ulcer syndrome in endoscopic biopsy specimens. Am J Surg Pathol 1998; 22: 106–112.
115. Lobert PF, Appelman HD. Inflammatory cloacogenic polyp: a unique inflammatory lesion of the anal transition zone. Am J Surg Pathol 1981; 5: 761.
116. Saul SH. Inflammatory cloacogenic polyp: relationship to solitary rectal ulcer syndrome/mucosal prolapse and other bowel disorders. Hum Pathol 1987; 18: 1120–1125.
117. Burke AP, Sobin LH. Eroded polypoid hyperplasia of the rectosigmoid. Am J Gastroenterol 1990; 85: 975–980.
118. Goldstein NS, Ahmad E. Histology of the mucosa in sigmoid colon specimens with diverticular disease: observations for the interpretation of sigmoid colonoscopic biopsy specimens. Am J Clin Pathol 1997; 107: 438–444.
119. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182–205.
120. Rubin DT, Hanauer SB. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000; 12: 855–862.
121. Dassopoulos T, Hanauer S. Presentation and diagnosis of inflammatory bowel disease. In: Cohen RD, ed. Inflammatory Bowel Disease. Totowa, NJ: Humana Press; 2003.
122. Munkholm P. The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Phar Ther 2003; 18(Suppl 2): 1–5.
123. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124: 521–536.
124. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NODF2 variants on Crohn’s disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393–2404.
125. Wehkamp J, Schmid M, Fellermann K, Stange EF. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn’s disease. J Leukoc Biol 2005; 77: 460–65.
126. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci USA 2005; 102: 18129–18134.
127. Fellermann K, Stange DE, Schaeffeler E, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79: 439–448.
128. Fisher SA, Tremelling M, Anderson CA, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet 2008; 40: 710–712.
129. Liu Y, van Kruiningen HJ, West AB, et al. Immunohistochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease. Gastroenterology 1995; 108: 1396–1404.
130. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology 1998; 115: 1405–1413.
131. Chamberlin W, Graham DY, Hulten K, et al. Mycobacterium avium subsp. paratuberculosis as one cause of Crohn’s disease. Aliment Pharm Therapeut 2001; 15: 337–346.
132. Ryan P, Bennett MW, Aarons S, et al. PCR detection of Mycobacterium paratuberculosis in Crohn’s disease granulomas isolated by laser capture microdissection. Gut 2002; 51: 665–670.
133. Lamps LW, Madhusudhan KT, Havens JM, et al. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn’s disease. Am J Surg Pathol 2003; 27: 220–227.
134. Baksh FK, Finkelstein SD, Ariyanayagam-Baksh SM, et al. Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn’s disease. Mod Pathol 2004; 17: 1289–1294.
135. Surawicz CM, Belic L. Rectal biopsy helps distinguish acute self limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 1984; 86: 104–113.
136. Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology 1987; 92: 318–328.
137. Schumacher G, Sandstedt B, Kollberg B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Scand J Gastroenterol 1994; 29: 265–274.
138. Tanaka M, Riddell RH, Saito H, et al. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn’s disease from ulcerative colitis. Scand J Gastroenterol 1999; 34: 55–67.
139. Kuramoto S, Oohara T, Ihara O, Shimazu R, Kondo Y. Granulomas of the gut in Crohn’s disease. A step sectioning study. Dis Colon Rectum 1987; 30: 6–11.
140. Mahadeva U, Martin JP, Patel NK, Price AB. Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn’s disease from ulcerative colitis. Histopathology 2002: 41: 50–55.
141. Bernstein CN, Shanahan F, Anton PA, Weinstein WM. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc 1995; 42: 232–237.
142. Kim B, Barnett JL, Kleer CG, Appelman HD. Endoscopic and histologic patchiness in treated ulcerative colitis. Am J Gastroenterol 1999; 94: 3259–3262.
143. Nugent FW, Roy MA. Duodenal Crohn’s disease; an analysis of 89 cases. Am J Gastroenterol 1989; 84: 249–254.
144. Schmidt-Sommerfeld E, Kirschner BS, Stephens JK. Endoscopic and histologic findings in the upper gastrointestinal tract of children with Crohn’s disease. J Pediatr Gastroenterol Nutr 1990; 11: 448–454.
145. Valdez R, Appelman HD, Bronner MP, Greenson JK. Diffuse duodenitis associated with ulcerative colitis. Am J Surg Pathol 2000; 24: 1407–1413.
146. Lengeling RW. Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents. Clin Gastroenterol Hepatol 2003; 1: 160–169.
147. Cuvelier C, Demetter P, Mielants H, Veys EM, De Vos M. Interpretation of ileal biopsies: morphological features in normal and diseased mucosa. Histopathology 2001; 38: 1–12.
148. Kleer CG, Appelman HD. Ulcerative colitis: pattern of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 1998; 22: 983–989.
149. Schumacher G, Kolberg B, Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol 1994; 29: 318–332.
150. Lashner BA, Turner BC, Bostwick DG, Frank PH, Hanauer SB. Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci 1990; 35: 349–352.
151. Goldblum JR, Appelman HD. Appendiceal involvement in ulcerative colitis. Mod Pathol 1992; 5: 607–610.
152. Groisman GM, George J, Harpaz N. Ulcerative appendicitis in universal and nonuniversal ulcerative colitis. Mod Pathol 1994; 7: 322–325.
153. Kroft SH, Stryker SJ, Rao MS. Appendiceal involvement as a skip lesion in ulcerative colitis. Mod Pathol 1994; 7: 912–914.
154. Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg 1996; 224: 563–573.
155. Wolfe BG. Resection margins in Crohn’s disease. Br J Surg 2001; 88: 771–772.
156. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology 1995; 109: 404–413.
157. Sheehan AL, Warren BF, Gear MW, Shepherd NA. Fat-wrapping in Crohn’s disease: pathological basis and relevance to surgical practice. Br J Surg 1992; 79: 955–958.
158. Wakefield AJ, Sankey EA, Dhillon AP, et al. Granulomatous vasculitis in Crohn’s disease. Gastroenterology 1991; 100: 1279–1287.
159. Matson AP, Van Kruiningen HJ, West AB, et al. The relationship of granulomas to blood vessels in intestinal Crohn’s disease. Mod Pathol 1995; 8: 680–685.
160. Lee EY, Stenson WF, DeSchryver-Kecskemeti K. Thickening of the muscularis mucosae in Crohn’s disease. Mod Pathol 1991; 4: 87–90.
161. Ariel I, Vinograd I, Hershlag A, et al. Crohn’s disease isolated to the appendix: truths and fallacies. Hum Pathol 1986; 17: 1116–1121.
162. Huang JC, Appleman HD. Another look at chronic appendicitis resembling Crohn’s disease. Mod Pathol 1996; 9: 975–981.
163. Swan NC, Geoghegan JG, O’Donoghue DP, Hyland JM, Sheahan K. Fulminant colitis in inflammatory bowel disease. Dis Colon Rectum 1998; 41: 1511–1515.
164. Guindi M, Riddell RH. Indeterminate colitis. J Clin Pathol 2004; 57: 1233–1244.
165. Farmer M, Petras RE, Hunt LE, Janosky JE, Galandiuk S. The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol 2000; 95: 3184–3188.
166. Braveman JM, Schoetz DJ Jr, Marcello PW, et al. The fate of the ileal pouch in patients developing Crohn’s disease. Dis Colon Rectum 2004; 47: 1613–1619.
167. Sagar PM, Dozois RR, Wolff BG. Long-term results of ileal pouch–anal anastomosis in patients with Crohn’s disease. Am J Gastroenterol 2001; 96: 730–734.
168. Yu CS, Pemberton JH, Larson D. Ileal pouch–anal anastomosis in patients with indeterminate colitis. Dis Colon Rectum 2000; 43: 1487–1496.
169. Gramlich T, Delaney CP, Lynch AC, Remzi FH, Fazio VW. Pathological subgroups may predict complications but not late failure after ileal pouch–anal anastomosis for indeterminate colitis. Colorectal Dis 2003; 5: 315–319.
170. Pishori T, Dinnewitzer A, Zmora O, et al. Outcome of patients with indeterminate colitis undergoing a double-stapled ileal pouch–anal anastomosis. Dis Colon Rectum 2004; 47: 717–721.
171. Dayton MT, Larsen KR, Christiansen DD. Similar functional results and complications after ileal–anal anastomosis in patients with indeterminate vs. ulcerative colitis. Arch Surg 2002; 137: 690–694.
172. D’Haens G, Geboes K, Peeters M, et al. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol 1997; 8: 1275–1279.
173. Kim B, Barnett JL, Kleer CG, et al. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol 1999; 94: 3258–3262.
174. Odze R, Antonioli D, Peppercorn M, Goldman H. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol 1993; 17: 869–875.
175. Markowitz J, Kahn E, Grancher K, et al. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol 1993; 88: 2034–2037.
176. Washington K, Greenson JK, Montgomery E, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol 2002; 26: 1141–1149.
177. Makapugay LM, Dean PJ. Diverticular disease-associated chronic colitis. Am J Surg Pathol 1996; 20: 94–102.
178. Gledhill A, Dixon MF. Crohn’s-like reaction in diverticular disease. Gut 1998; 42: 392–395.
179. Goldstein NS, Leon-Armin C, Mani A. Crohn’s colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to diverticular disease rather than Crohn’s colitis. Am J Surg Pathol 2000; 24: 668–675.
180. Pereira MC. Diverticular disease-associated colitis: progression to severe chronic ulcerative colitis after sigmoid surgery. Gastrointest Endosc 1998; 48: 392–395.
181. Lasner BBA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis: result from a surveillance program. Dig Dis Sci 1989; 34: 1536–1541.
182. Kornfield D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997; 41: 522–525.
183. Brenthill TA, Haggitt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110: 331–338.
184. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931–968.
185 Dixon MF, Brown LJ, Gilmour HM, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988; 13: 385–397.
186. Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 1989; 20: 1008–1014.
187. Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 2001; 194: 152–157.
188. Löfberg R, Broström O, Karlén P, Ost A, Tribukait B. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 1992; 102: 1149–1154.
189. Wong NA, Mayer NJ, MacKell S, Gilmour HM, Harrison DJ. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 2000; 37: 108–114.
190. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80: 366–374.
191. Walsh SV, Loda M, Torres CM, et al. P53 and beta catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol 1999; 23: 963–969.
192. Mueller E, Vieth M, Stolte M, et al. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol 1999; 30: 898–905.
193. Odze RD, Brown CA, Hartmann CJ, et al. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am J Surg Pathol 2000; 24: 1209–1216.
194. Fogt F, Urbanski SJ, Sanders ME, et al. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis. Hum Pathol 2000; 31: 288–291.
195. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999; 117: 1295–1300.
196. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004; 2: 534–541.
197. Pemberton JH, Kelly KA, Beart RW Jr, et al. Ileal pouch–anal anastomosis for chronic ulcerative colitis: long term results. Ann Surg 1987; 206: 504–513.
198. Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology 2003; 124: 1636–1650.
199. Krausz MM, Duek SD. Restorative proctocolectomy with ileal pouch–anal anastomosis for ulcerative colitis and familial adenomatous polyposis: twenty years follow-up in 174 patients. Israel Med Assoc J 2005; 7: 23–27.
200. Colombel JF, Ricart E, Loftus EV Jr, et al. Management of Crohn’s disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003; 98: 2239–2244.
201. Sheperd NA, et al. Workshop: pouchitis. Int J Colorectal Dis 1989; 4: 205–229.
202. Warren BF, Sheperd NA. The role of pathology in pelvic ileal reservoir surgery. Int J Colorectal Dis 1992; 7: 68–75.
203. Chiefetz A, Itzkowitz S. The diagnosis and management of pouchitis in inflammatory bowel disease. J Clin Gastroenterol 2004; 38(5 Suppl): S44–S50.
204. Yantiss RK, Sapp HL, Farraye FA, et al. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol 2004; 28: 999–1006.
205. Shephard NA, Jass JR, Duval I, et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987; 40: 601–607.
206. Apel R, Cohen Z, Andrews CW Jr, et al. Prospective evaluation of early morphologic changes in pelvic ileal pouches. Gastroenterology 1994; 107: 435–443.
207. Goldstein NS, Sanford WW, Bodzin JH. Crohn’s-like complications in patients with ulcerative colitis after total proctocolectomy and ileal-anal anastomosis. Am J Surg Pathol 1998; 21: 1343–1353.
208. Glotzer DJ, Bethwaite PB, Prasad J, Isbister WH. Proctitis and colitis following diversion of the faecal stream. Gastroenterology 1981; 80: 438–441.
209. Murray FE, O’Brien MJ, Birkett DH, Kennedy SM, LaMont JT. Diversion colitis. Pathologic findings in a resected sigmoid colon and rectum. Gastroenterology 1987; 93: 1404–1408.
210. Geraghty JM, Talbot IC. Diversion colitis: histologic features in the colon and rectum after defunctioning colostomy. Gut 1991; 32: 1020–1023.
211. Komorowski RA. Histologic spectrum of diversion colitis. Am J Surg Pathol 1990; 14: 548–554.
212. Ma CK, Gottlieb C, Haas PA. Diversion colitis: a clinicopathological study of 21 cases. Hum Pathol 1990; 21: 429–436.
213. Korelitz BI, Cheskin LJ, Sohn N, Sommers SC. Proctitis after faecal diversion in Crohn’s disease and its elimination with reanastomosis: implications for surgical management. Gastroenterology 1984; 87: 1171–1173.
214. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain fatty acid irrigation. N Engl J Med 1989; 320: 23–28.
215. Yeong ML, Bethwaite PB, Prasad J, Isbister WH. Lymphoid follicular hyperplasia – a distinctive feature of diversion colitis. Histopathology 1991; 19: 55–61.
216. Warren BF, Sheperd NA. Diversion proctocolitis. Histopathology 1992; 21: 91–93.
217. Flejou JF, Potet F, Bogomoletz WV, et al. Lymphoid follicular proctitis. A condition different from ulcerative proctitis? Dig Dis Sci 1988; 33: 314–320.
218. Barbut F, Beaugerie L, Delas N, et al. Comparative value of colonic biopsy and intraluminal fluid culture for diagnosis of bacterial colitis in immunocompetent patients. Infectious Colitis Study Group. Clin Infect Dis 1999; 29: 356–360.
219. Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004; 16: 775–778.
220. Lamps LW. Infectious diseases of the GI tract. In: Odze RD, Goldblum JR, Crawford JM, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Philadelphia, PA: WB Saunders; 2004.
221. Gonzalez A, Vargas V, Guarner L, Accarino A, Guardia J. Toxic megacolon in typhoid fever. Arch Intern Med 1985; 145: 2120.
222. Day DW, Mandal BK, Morson BC. The rectal biopsy appearances in Salmonella colitis. Histopathology 1978; 2: 117.
223. Kraus MD, Amatya B, Kimula Y. Histopathology of typhoid enteritis: morphologic and immunophenotypic findings. Mod Pathol 1999; 12: 949–955.
224. Boyd JF. Pathology of the alimentary tract in Salmonella typherium food poisoning. Gut 1985; 26: 935–944.
225. McGovern VJ, Slavutin LJ. Pathology of Salmonella colitis. Am J Surg Pathol 1979; 3: 484–490.
226. Bradford WED, Noce PS, Gutman LT. Pathologic features of enteric infection with Yersinia enterocolitica. Arch Pathol 1974; 98: 17.
227. El-Maraghi, Mair NS. The histopathology of enteric infection with Yersinia pseudotuberculosis. Am J Clin Pathol 1979; 71: 631–639.
228. Gleason TH, Patterson SD. The pathology of Yersinia enterocolitica ileocolitis. Am J Surg Pathol 1982; 6: 347–355.
229. Lamps LW, Madhusudhan KT, Greenson JK, et al. The role of Y. enterocolitica and Y. pseudotuberculosis in granulomatous appendicitis: a histologic and molecular study. Am J Surg Pathol 2001; 25: 508–515.
230. Willoughby CP, Piris J, Truelove SC. Campylobacter colitis. J Clin Pathol 1979; 32: 986.
231. Price AB, Jewkes J, Sanderson PJ. Acute diarrhoea: Campylobacter colitis and the role of rectal biopsy. J Clin Pathol 1979; 32: 990.
232. van Spreeuwel JP, Duursma GC, Meijer CJ, et al. Campylobacter colitis: histological, immunohistochemical, and ultrastructural findings. Gut 1985; 26: 945–951.
233. Appelman HD. Toxic megacolon due to Campylobacter colitis. Int J Colorectal Dis 1987; 2: 49.
234. Jackson TL Jr, Young RL, Thompson JS, McCashland TM. Toxic megacolon associated with Campylobacter jejuni colitis. Am J Gastroenterol 1999; 94: 280–282.
235. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257–262.
236. Nash SV, Bourgeault R, Sands M. Colonic disease associated with a positive assay for Clostridium difficile toxin: a retrospective study. J Clin Gastroenterol 1997; 225: 476–479.
237. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739–750.
238. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1: 1–18.
239. El-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE. Eradication of Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060–1065.
240. Olbe L, Hamlet A, Dalenbäck J, Fändriks L. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996; 110: 1386–1394.
241. Graham DY. Helicobacter pylori and perturbations in acid secretion: the end of the beginning. Gastroenterology 1996; 110: 1647–1650.
242. Kreuning J, vd Wal AM, Kuiper G, Lindeman J. Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease. Scand J Gastroenterol 1989; 24(Suppl 167): 16–20.
243. Bernheim J, Novis BH. Heterotopic and metaplastic gastric mucosa in the duodenum. Isr J Med Sci 1989; 25: 321–323.
244. Wyatt JI, Rathbone BJ, Dixon MF, Heatley RV. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987; 40: 841–848.
245. Wyatt JI, Rathbone BJ, Sobala GM, et al. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990; 43: 981–986.
246. Johan G, Offerhaus A, Molyvas EN, Hoedemaeker PJ. Helicobacter pylori infection of gastric mucin cell metaplasia: the duodenum revisited. J Pathol 1990; 162: 239–243.
247. Noach LA, Rolf TM, Bosma NB, et al. Gastric metaplasia and Helicobacter pylori infection. Gut 1993; 34: 1510–1514.
248. Fitzgibbons PL, Dooley CP, Cohen H, Appleman MD. Prevalence of gastric metaplasia, inflammation, and Campylobacter pylori in the duodenum of members of a normal population, Am J Clin Pathol 1988; 90: 711–714.
249. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–1235.
250. Khulusi S, Badve S, Patel P, et al. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid and ulceration. Gastroenterology 1996; 110: 452–458.
251. Bästlein CH, Decking R, Voeth C, Ottenjann R. Giant Brunneroma of the duodenum. Endoscopy 1988; 20: 154–155.
252. Matsui K, Kitagawa M. Biopsy study of polyps in the duodenal bulb. Am J Gastroenterol 1993; 88: 253–257.
253. Parrish J, Rawlins D. Intestinal mucosa in Zollinger–Ellison syndrome. Gut 1965; 6: 286–289.
254. Urbach DR, Rotstein OD. Typhilitis. Can J Surg 1999; 42: 415–420.
255. Bavaro MF. Neutropenic enterocolitis. Curr Gastroenterol Rep 2002; 4: 297–301.
256. Wach M, Dmoszynska A, Wasik-Szczepanek E, et al. Neutropenic enterocolitis: a serious complication during treatment of acute leukemias. Ann Hematol 2004; 83: 522–526.
257. Gomez L, Martino R, Rolston KV. Neutropenic enterocolitis: spectrum of disease and comparison of definite and possible cases. Clin Infect Dis 1998; 27: 695–699.
258. Capria S, Vitolo D, Cartoni C, et al. Neutropenic enterocolitis in acute leukemia: diagnostic and therapeutic dilemma. Ann Hematol 2004; 83: 195–197.
259. Wade DS, Nava HR, Douglass HO Jr. Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 1992; 69: 17–23.
260. Tait RA, Kealy WF. Neonatal necrotizing enterocolitis. J Clin Pathol 1979; 32: 1090–1099.
261. Kanto WP, Wilson R, Breart GL, et al. Perinatal events and necrotizing enterocolitis in premature infants. Am J Dis Child 1987; 141: 167–169.
262. Cheromcha DP, Hyman PE. Neonatal necrotizing enterocolitis: inflammatory bowel disease of the newborn. Dig Dis Sci 1988; 33(Suppl): 78S–84S.
263. Maayan-Metzger A, Itzchak A, Mazkereth R, Kuint J. Necrotizing enterocolitis in full-term infants: case-control study and review of the literature. J Perinatol 2004; 24: 494–499.
264. Hsueh W, Caplan MS, Qu XW, et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Develop Pathol 2002; 6: 6–23.
265. Ballance WA, Dahms BB, Shenker N, Kliegman RM. Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 1990; 117(Suppl): S6–S13.
266. Rosen T, Won OH. Phlegmonous enterocolitis. Am J Dig Dis 1978; 23: 248–256.
267. Surawicz CM, Roberts PL, Rompalo A, et al. Intestinal spirochetosis in homosexual men. Am J Med 1987; 82: 587–592.
268. Ruane PJ, Nakata MM, Reinhardt JF, George WL. Spirochete-like organisms in the human gastrointestinal tract. Rev Infectious Dis 1989; 11: 185–195.
269. McMillan A, Lee FD. Sigmoidoscopic and microscopic appearance of the rectal mucosa in homosexual men. Gut 1981; 22: 1035–1041.
270. Surawicz CM, Goodell SE, Quinn TC, et al. Spectrum of rectal biopsy abnormalities in homosexual men with intestinal symptoms. Gastroenterology 1986; 91: 651–659.
271. Tabrisky J, Lindstrom RR, Peters R, Lachman RS. Tuberculosis enteritis. Am J Gastroenterol 1975; 63: 49–57.
272. Howell JS, Knapton PJ. Ileo-caecal tuberculosis. J Br Soc Gastroenterol (Gut) 1964; 5; 524–529.
273. Wallace JM, Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. Chest 1988; 93: 926–932.
274. Hellyer TJ, Brown IN, Taylor MB, Allen BW, Easmon CS. Gastrointestinal involvement in Mycobacterium avium-intracellulare infection of patients with HIV. J Infect 1993; 26: 55–66.
275. Surawicz CM, Myerson D. Self-limited cytomegalovirus colitis in immunocompetent individuals. Gastroenterology 1988; 94: 194–199.
276. Hinnant KL, Rotterdam HZ, Bell ET, Tapper ML. Cytomegalovirus infection of the alimentary tract: a clinicopathological correlation. Am J Gastroenterol 1986; 81: 944–950.
277. Chetty R, Roskell DE. Cytomegalovirus infection in the gastrointestinal tract. J Clin Pathol 1994; 47: 968–972.
278. Strickler JG, Singleton TP, Copenhaver CM, Erice A, Snover DC. Adenovirus in the gastrointestinal tracts of immunosuppressed patients. Am J Clin Pathol 1992; 97: 555–558.
279. Montgomery EA, Popek EJ. Intussusception, adenovirus, and children: a brief reaffirmation. Hum Pathol 1994; 25: 169–174.
280. Orenstein JM, Dieterich DT. The histopathology of 103 consecutive colonoscopic biopsies from 82 symptomatic patients with acquired immunodeficiency syndrome: original and look-back diagnoses. Arch Pathol Lab Med 2001; 125: 1042–1046.
281. Porter HJ, Padfield CJ, Peres LC, Hirschowitz L, Berry PJ. Adenovirus and intranuclear inclusions in appendices in intussusception. J Clin Pathol 1993; 46: 154–158.
282. Nakagomi T. Rotavirus infection and intussusception: a view from retrospect. Microbiol Immunol 2000; 44: 619–628.
283. Klausner JD, Kohn R, Kent C. Etiology of clinical proctitis among men who have sex with men. Clin Infect Dis 2004; 38: 300–302.
284. Delis S, Kato T, Ruiz P, et al. Herpes simplex colitis in a child with combined liver and small bowel transplant. Pediatr Transplant 2001; 5: 374–377.
285. Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol 1992; 45: 806–811.
286. Bond S, Stewart DL, Bendon RW. Invasive Candida enteritis of the newborn. J Pediatr Surg 2000; 35: 1496–1498.
287. Gupta TP, Ehrinpreis MN. Candida-associated diarrhea in hospitalized patients. Gastroenterology 1990; 98: 780–785.
288. Cappell MS, Mandell W, Grimes MM, Neu HC. Gastrointestinal histoplasmosis. Dig Dis Sci 1988; 33: 353–360.
289. Lamps LW, Molina CP, West AB, Haggitt RC, Scott MA. The pathologic spectrum of gastrointestinal and hepatic histoplasmosis. Am J Clin Pathol 2000; 113: 64–72.
290. Brandt H, Tamayo PP. Pathology of human amebiasis. Hum Pathol 1970; 1: 351–385.
291. Prathap K, Gilman R. The histopathology of acute intestinal amebiasis: a rectal biopsy study. Am J Pathol 1970; 60: 229–246.
292. Radke RA. Ameboma of the intestine: an analysis of the disease as presented in 78 collected cases and 41 previously unreported cases. Ann Intern Med 1955; 43: 1048–1066.
293. Ellyson JH, Bezmalinovic Z, Parks SN, Lewis FR Jr. Necrotizing amebic colitis: a frequently fatal complication. Am J Surg 1986; 152: 21–26.
294. Oberhuber D, Kastner N, Stolte M. Giardiasis: a histologic analysis of 567 cases. Scand J Gastroenterol 1997; 32: 48–51.
295. Clayton F, Heller T, Kotler DP. Variation in the distribution of Cryptosporidia in acquired immunodeficiency syndrome. Am J Clin Pathol 1994; 102: 420–425.
296. Aragon TJ, Novotny S, Enanoria W, et al. Endemic cryptosporidiosis and exposure to municipal tap water in patients with acquired immunodeficiency syndrome (AIDS): a case control study. BMC Publ Hlth 2003; 3: 2.
297. Lefkowitch JH, Krumholz S, Feng-Chen KC, et al. Cryptosporidiosis of the human small intestine: a light and electron microscope study. Hum Pathol 1984; 15: 746–752.
298. Moore JA, Frenkel JK. Respiratory and enteric cryptosporidiosis in humans. Arch Pathol Lab Med 1991; 115: 1160–1162.
299. Marshall JB, Singh R, Diaz-Arias AA. Chronic, unexplained diarrhea: are biopsies necessary if colonoscopy is normal? Am J Gastroenterol 1995; 90: 372–376.
300. Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhoea. Gastrointest Endosc 2000; 51: 318–326.
301. Fernandez-Banares F, Salas A, Esteve M, et al. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003; 98: 340–347.
302. Camarero C, Leon F, Colino E, et al. Collagenous colitis in children: clinicopathologic, microbiologic and immunologic features. J Pediatr Gastroentol Nutr 2003; 37: 508–513.
303. Mahajan L, Wyllie R, Goldblum J. Lymphocytic colitis in a pediatric patient: a possible adverse reaction to carbamazepine. Am J Gastroenterol 1997; 92: 2126–2127.
304. Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 1992; 33: 683–686.
305. Thomson RD, Lestina LS, Bensen SP, et al. Lansoprazole-associated microscopic colitis: a case series. Am J Gastroenterol 2002; 97: 2908–2913.
306. Padmanabhan V, Callas PW, Li SC, Trainer TD. Histopathological features of the terminal ileum in lymphocytic and collagenous colitis: a study of 32 cases and review of the literature. Mod Pathol 2003; 16: 115–119.
307. Sapp H, Ithamukkala S, Brien TP, et al. The terminal ileum is affected in patients with lymphocytic or collagenous colitis. Am J Surg Pathol 2002; 26: 1484–1492.
308. Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004; 53: 536–541.
309. Pardi S, Ramnath VR, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 2002; 97: 2829–2833.
310. Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002; 123: 978–984.
311. Shaz BH, Reddy SI, Ayata G, et al. Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. Mod Pathol 2004; 17: 395–401.
312. Lindstrom CG. ‘Collagenous colitis’ with watery diarrhoea: a new entity? Pathol Eur 1976; 11: 87–89.
313. Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol 1987; 18: 839–848.
314. Offner FA, Jao RV, Lewin KJ, Havelec L, Weinstein WM. Collagenous colitis: a study of the distribution of morphologic abnormalities and their histologic distribution. Hum Pathol 1999; 30: 451–457.
315. Lee E, Schiller LR, Vendrell D, Santa Ana CA, Fordtran JS. Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology 1992; 103: 1790–1796.
316. Lazenby AJ, Yardley JH, Giardiello FM, Bayless TM. Pitfalls in the diagnosis of collagenous colitis. Experience with 75 cases from a registry of collagenous colitis at Johns Hopkins Hospital. Hum Pathol 1990; 21: 905–910.
317. Salas A. Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology 2003; 43: 48–54.
318. Muller S, Neureiter D, Stolte M, et al. Tenascin: a sensitive and specific diagnostic marker of minimal collagenous colitis. Virchows Archiv 2001; 438: 435–441.
319. Groisman GM, Lachter J, Vlodavsky E. Amyloid colitis mimicking collagenous colitis. Histopathology 1997; 31: 201–202.
320. Read NW, Krejs GJ, Read MG, et al. Chronic diarrhea of unknown origin. Gastroenterology 1980; 78: 264–271.
321. Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic (‘microscopic’) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989; 20: 18–28.
322. Lee E, Schiller LR, Fordtran JS. Quantification of colonic lamina propria cells by means of a morphometric point-counting method. Gastroenterology 1988; 94: 409–418.
323. Wang N, Dumot JA, Achkar E, et al. Colonic epithelial lymphocytosis without a thickened subepithelial collagen table: a clinicopathologic study of 40 cases supporting a heterogeneous entity. Am J Surg Pathol 1999; 23: 1068–1074.
324. Baert F, Wouters K, D’Haens G, et al. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 1999; 45: 375–381.
325. Ayata G, Ithamukkala S, Sapp H, et al. Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol 2002; 26: 1414–1423.
326. Mosnier JF, Larvol L, Barge J, et al. Lymphocytic and collagenous colitis: an immunohistochemical study. Am J Gastroenterol 1996; 91: 709–713.
327. Libbrecht L, Croes R, Ectors N, Staels F, Geboes K. Microscopic colitis with giant cells. Histopathology 2002; 40: 335–338.
328. Saurine TJ, Brewer JM, Eckstein RP. Microscopic colitis with granulomatous inflammation. Histopathology 2004; 45: 82–86.
329. Sandmier D, Bouzourene H. Microscopic colitis with giant cells: a rare new histologic subtype? Int J Surg Pathol 2004; 12: 45–48.
330. Lee FD. Drug related pathologic lesions of the intestinal tract. Histopathology 1994; 24: 303–308.
331. Price AB. Pathology of drug-associated gastrointestinal disease. Br J Clin Pharmacol 2003; 56: 477–482.
332. Lee FD. Importance of apoptosis in the histopathology of drug related lesions of the large intestine. J Clin Pathol 1993; 46: 118–122.
333. Ghadially FN, Walley VM. Melanoses of the gastrointestinal tract. Histopathology 1994; 25: 197–207.
334. Pawel BR, de Chadarévian JP, Franco ME. The pathology of fibrosing colopathy of cystic fibrosis: a study of 12 cases and review of the literature. Hum Pathol 1997; 28: 395–399.
335. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832–1837.
336. Chutkan R, Toubia N. Effect of nonsteroidal anti-inflammatory drugs on the gastrointestinal tract: diagnosis by wireless capsule endoscopy. Gastrointest Endosc Clin North Am 2004; 14: 67–85.
337. Puspok A, Kiener HP, Oberhuber G. Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 2000; 43: 685–691.
338. Foutch PG. Diverticular bleeding: are non-steroidal anti-inflammatory drugs risk factors for hemorrhage and can colonoscopy predict outcome for patients? Am J Gastroenterol 1995; 90: 1779–1784.
339. Goldstein NS, Cinenza AN. The histopathology of nonsteroidal anti-inflammatory drug-associated colitis. Am J Clin Pathol 1998; 110: 622–628.
340. Gargot D, Chaussade S, d’Alteroche L, et al. Nonsteroidal anti-inflammatory drug-induced colonic strictures: two cases and literature review. Am J Gastroenterol 1995; 90: 2035–2038.
341. Baert F, Hart J, Blackstone MO. A case of diclofenac-induced colitis with focal granulomatous change. Am J Gastroenterol 1995; 90: 1871–1873.
342. Kakar S, Pardi DS, Burgart LJ. Colonic ulcers accompanying collagenous colitis: implication of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 2003; 98: 1834–1837.
343. Terdiman JP, Linker CA, Ries CA, et al. The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone marrow transplantation. Endoscopy 1996; 28: 680–685.
344. Roy J, Snover D, Weisdorf S, et al. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation 1991; 51: 642–646.
345. Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of 13 patients. Gastroenterology 1980; 78: 764–771.
346. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versus-host disease in man: a clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291–299.
347. Snover DC. Mucosal damage simulating acute graft-versus-host disease in cytomegalovirus colitis. Transplantation 1985; 39: 669–670.
348. Wang MH, Wong JM, Wang CY. Graft-versus-host disease-like syndrome in malignant thymoma. Scand J Gastroenterol 2000; 35: 667–670.
349. Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 1996; 20: 1240–1252.
350. Papadimitriou JC, Drachenberg CB, Beskow CO, et al. Graft-versus-host-like features in mycophenolate mofetil-related colitis. Transpl Proc 2001; 33: 2237–2238.
351. Washington K, Bentley RC, Green A, et al. Gastric graft-versus-host disease: a blinded histologic study. Am J Surg Pathol 1997; 21: 1037–1046.
352. Asplund S, Gramlich TL. Chronic mucosal changes of the colon in graft-versus-host disease. Mod Pathol 1998; 11: 513–515.
353. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
354. Bodian M, Carter C. A family study of Hirschsprung’s disease. Ann Hum Genet 1963; 26: 261.
355. Amiel J, Lyonnet S. Hirschsprung’s disease, associated syndromes, and genetics: a review. J Med Genet 2001; 38: 729–739.
356. Lewis NA, Levitt MA, Zallen GS, et al. Diagnosing Hirschsprung’s disease: increasing the odds of a positive rectal biopsy result. J Pediatr Surg 2003; 38: 412–416.
357. Blisard KS, Kleinman R. Hirschsprung’s disease. A clinical and pathologic overview. Hum Pathol 1986; 17: 1189–1191.
358. Yunis EJ, Dibbins AW, Sherman FE. Rectal suction biopsy in the diagnosis of Hirschsprung’s disease in infants. Arch Pathol Lab Med 1976; 100: 329–333.
359. Aldridge RT, Campbell PE. Ganglion cell distribution in the normal rectum and anal canal. A basis for the diagnosis of Hirschsprung’s disease by anorectal biopsy. J Pediatr Surg 1968; 3: 475–490.
360. Venugopai S, Mancer K, Shandling B. The validity of rectal biopsies in relation to morphology and distribution of ganglion cells. J Pediatr Surg 1981; 16: 433–437.
361. Abu-Alfa A, Kuan SF, West AB, Reyes-Múgica M. Cathepsin D in intestinal ganglion cells. A potential aid to diagnosis in suspected Hirschsprung’s disease. Am J Surg Pathol 1997; 21: 201–205.
362. Taguchi T, Tanaka K, Ikeda K. Immunohistochemical study of neuron specific enolase and S-100 protein in Hirschsprung’s disease. Virchows Arch [A] 1985; 405: 399.
363. Monforte-Munoz H, Gonzalez-Gomez I, Rowland JM, Landing BH. Increased submucosal nerve trunk caliber in aganglionosis: a ‘positive’ and objective finding in suction biopsies and segmental resections in Hirschsprung’s disease. Arch Pathol Lab Med 1998; 122: 721–725.
364. Robey SS, Kuhajda FP, Yardley JH. Immunoperoxidase stains on ganglion cells and abnormal mucosal nerve proliferations in Hirschsprung’s disease. Hum Pathol 1988; 19: 432–437.
365. Challa VR, Moran JR, Turner CS, Lyerly AD. Histologic diagnosis of Hirschsprung’s disease. The value of concurrent hematoxylin and eosin and cholinesterase staining of rectal biopsies. Am J Clin Pathol 1987; 88: 324–328.
366. Sun C-CJ, Caniano DA, Hill JL. Intestinal aganglionosis. A histologic and acetylcholinesterase histochemical study. Pediatr Pathol 1987; 7: 421–435.
367. Lake BD, et al. Letter to the editor. Pediatr Pathol 1989; 9: 351–354.
368. Barshack I, Fridman E, Goldberg I, Chowers Y, Kopolovic J. The loss of calretinin expression indicates aganglionosis in Hirschsprung’s disease. J Clin Pathol 2004; 57: 712–716.
369. Guinard-Samuel V, Bonnard A, De Lagausie P, et al. Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung disease. Mod Pathol 2009; 22: 1379–1384.
370. Gherardi GJ. Pathology of the ganglionic–aganglionic junction in congenital megacolon. Arch Pathol 1960; 69: 520–523.
371. Maia DM. The reliability of frozen-section diagnosis in pathologic evaluation of Hirschsprung’s disease. Am J Surg Pathol 2000; 24: 1625–1627.
372. Qualman SJ, Murray R. Aganglionosis and related disorders. Hum Pathol 1994; 25: 1141–1149.
373. Teitelbaum DH, Qualman SJ, Caniano DA. Hirschsprung’s disease, identification of risk factors for enterocolitis. Ann Surg 1988; 207: 240–244.
374. Scharli AF, Meier-Ruge W. Localized and disseminated forms of neuronal intestinal dysplasia mimicking Hirschsprung’s disease. J Ped Surg 1981; 16: 164.
375. Schofield DE, Yunis EJ. What is intestinal neuronal dysplasia? Pathol Annu 1992; 1: 249–262.
376. Lumb PD, Moore L. Back to the drawing board. Intestinal neuronal dysplasia type B: not a histologic entity yet. Virchows Arch 1998; 432: 99–102.
377. Beart RW. Acute pseudo-obstruction of the colon (Ogilvie’s syndrome). An analysis of 400 cases. Dis Colon Rectum 1986; 29: 203–210.
378. Freilich HS, Chopra S, Gilliam JI. Acute colonic pseudo-obstruction or Ogilvie’s syndrome. Report of two cases treated with colonoscopic decompression and review of the literature. J Clin Gastroenterol 1986; 8: 457–460.
379. Verne GN, Sninsky CA. Chronic intestinal pseudo-obstruction. Dig Dis Sci 1995; 13: 163–181.
380. Anuras S, Mitros FA, Soper RT, et al. Chronic intestinal pseudoobstruction in young children. Gastroenterology 1986; 91: 62–70.
381. Krishnamurthy S, Schuffler MD. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 1987; 93: 610–639.
382. Koch TR, Carney JA, Go L, Go VL. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology 1988; 94: 300–310.
383. Boeckxstaens GE, Rumessen JJ, de Wit L, Tytgat GN, Vanderwinden JM. Abnormal distribution of the interstitial cells of Cajal in an adult patient with pseudo-obstruction and megaduodenum. Am J Gastroenterol 2002; 97: 2120–2126.
384. Lyford GL, He CL, Soffer E, et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut 2002; 51: 496–501.
385. Hasler WL. Is constipation caused by a lack of colonic interstitial cells of Cajal. Gastroenterology 2003; 125: 264–266.
386. Anuras S, Mitros FA, Nowak TV, et al. A familial visceral myopathy with external ophthalmoplegia and autosomal-recessive transmission. Gastroenterology 1983; 84: 346–353.
387. Lowsky R, Davidson G, Wolman S, Jeejeebhoy KN, Hegele RA. Familial visceral myopathy associated with a mitochondrial myopathy. Gut 1993; 34: 279–283.
388. Guze CD, Hyman PE, Payne VJ. Family studies of infantile visceral myopathy: a congenital myopathic pseudo-obstruction syndrome. Am J Med Genet 1999; 82: 114–122.
389. Horn T, Svendsen LB, Nielsen R. Brown-bowel syndrome. Review of the literature and presentation of cases. Scand J Gastroenterol 1990; 25: 66–72.
390. Joo JS, Ehrenpreis ED, Gonzalez L, et al. Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon. J Clin Gastroenterol 1998; 26: 283–286.
391. Gattuso JM, Kamm MA. Adverse effect of drugs used in the management of constipation and diarrhea. Drug Safety 1994; 10: 47–65.
392. Kouraklis G, Glinavou A, Mantas D, Kouskos E, Karatzas G. Clinical implications of small bowel diverticula. Israel Med Assoc J 2002; 4: 431–433.
393. Skar V, Skar AG, Osnes M. The duodenal bacterial flora in the region of the papilla of Vater in patients with and without duodenal diverticula. Scand J Gastroenterol 1989; 24: 649–656.
394. Akhrass R, Yaffe MB, Fischer C, Ponsky J, Shuck JM. Small-bowel diverticulosis: perceptions and reality. J Am Coll Surg 1997; 184: 383–388.
395. Berk RN. Scleroderma of the gastrointestinal tract. Am J Gastroenterol 1974; 61: 226–231.
396. St.-Vil D, Brandt ML, Panic S, Bensoussan AL, Blanchard H. Meckel’s diverticulum in children. A 20-year review. J Pediatr Surg 1991; 26: 1289–1292.
397. Cserni G. Gastric pathology in Meckel’s diverticulum. Review of cases resected between 1965 and 1995. Am J Clin Pathol 1996; 106: 782–785.
398. Williamson RC. Intussusception of invaginated Meckel’s diverticulum. J Roy Soc Med 1984; 77: 652–655.
399. Floch MH, Bina I. The natural history of diverticulitis. J Clin Gastroenterol 2004; 38(Suppl 1): S2–S7.
400. West AB, Losada M. The pathology of diverticulosis coli. J Clin Gastroenterol 2004; 38(Suppl 1): S11–S16.
401. Ferzoco LB, Raptopoulos V, Silen W. Acute diverticulitis. N Engl J Med 1998; 338: 1521–1526.
402. Machida HM, Catto Smith AG, Gall DG, Trevenen C, Scott RB. Allergic colitis in infancy: clinical and pathologic aspects. J Pediatr Gastroenterol Nutr 1994; 19: 22–26.
403. Iacono G, Cavataio F, Montalto G, et al. Intolerance of cow’s milk and chronic constipation. N Engl J Med 1998; 339: 1100–1104.
404. Nowak-Wegrzyn A, Sampson HA, Wood RA, Sicherer SH. Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics 2003; 111: 829–835.
405. Winter HS, Antonioli DA, Fukagawa N, Marcial M, Goldman H. Allergy-related proctocolitis in infants: diagnostic usefulness of rectal biopsy. Mod Pathol 1990; 3: 5–10.
406. Goldman H, Proujansky R. Allergic proctitis and gastroenteritis in children. Clinical and mucosal biopsy features in 53 cases. Am J Surg Pathol 1986; 10: 75–86.
407. Naylor AR, Pollet JE. Eosinophilic colitis. Dis Colon Rectum 1985; 28: 615–618.
408. Moore D, Lichtman S, Lentz J, Stringer D, Sherman P. Eosinophilic gastroenteritis presenting in an adolescent with isolated colonic involvement. Gut 1986; 27: 1219–1222.
409. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997; 337: 898–909.
410. Ganfi J, Sohar E. Rectal biopsy for the diagnosis of amyloidosis. Am J Med Sci 1960; 240: 332–336.
411. Kyle RA, Gertz MA, Lacy MQ, Dispenzieri A. Localized AL amyloidosis of the colon: an unrecognized entity. Amyloid 2003; 10: 36–41.
412. Matsui H, Kato T, Inoue G, Onji M. Amyloidosis localized in the sigmoid colon. J Gastroenterol 1996; 31: 607–611.
413. Hamaya K, Kitamura M, Doi K. Primary amyloid tumors of the jejunum producing intestinal obstruction. Acta Pathol Japonica 1989; 39: 207–211.
414. Senapati A, Fletcher C, Bultitude MI, Jackson BT. Amyloid tumour of the rectum. J Roy Soc Med 1995; 88: 48P–49P.
415. Deans GT, Hale RJ, McMahon RF, Brough WA. Amyloid tumour of the colon. J Clin Pathol 1995; 48: 592–593.
416. Yamada M, Hatakeyama S, Tsukagoshi H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum Pathol 1985; 16: 1206–1211.
417. Garcia-Gonzalez R, Fernández FA, Garijo MF, Fernando Val-Bernal J. Amyloidosis of the rectum mimicking collagenous colitis. Pathol Res Pract 1998; 194: 731–735.
418. Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc 1990; 36: 10–14.
419. Kumar SS, Appavu SS, Abcarian H, Barreta T. Amyloidosis of the colon: report of a case and review of the literature. Dis Colon Rectum 1983; 26: 541–544.
420. Galandiuk S, Fazio VW. Pneumatosis cystoides intestinalis: a review of the literature. Dis Colon Rectum 1986; 29: 358–363.
421. Suarez V, Chesner IM, Price AB, Newman J. Pneumatosis cystoides intestinalis. Histologic mucosal changes mimicking inflammatory bowel disease. Arch Pathol Lab Med 1989; 113: 898–901.
422. Heng Y, Schuffler MD, Haggitt RC, Rohrmann CA. Pneumatosis intestinalsis: a review. Am J Gastroenterol 1995; 90: 1747–1758.
423. Snover DC, Sandstad J, Hutton S. Mucosal pseudolipomatosis of the colon. Am J Clin Pathol 1985; 84: 575–580.
424. Weisbrot IM, Liber AF, Gordon BS. The effects of therapeutic radiation on colonic mucosa. Cancer 1975; 36: 931–940.
425. Green N, Goldberg H, Goldman H, Lombardo L, Skaist L. Severe rectal injury following radiation for prostatic cancer. J Urol 1984; 131: 710–714.
426. Tankel H, Clark DH, Lee FD. Radiation enteritis with malabsorption. Gut 1965; 6: 560.
427. Wiernik G. Changes in the villous pattern of the human jejunum associated with heavy radiation damage. Gut 1966; 7: 149.
428. Novak JM, Collins JT, Donowitz M, et al. Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol 1979; 1: 9–39.
429. Berthrong M, Fajardo LF. Radiation injury in surgical pathology. II. Alimentary tract. Am J Surg Pathol 1981; 5: 153–177.
430. Williams RA, Myers P. Pathology of the Appendix. London: Chapman & Hall Medical; 1994: p. 180.
431. Guidry SP, Poole GV. The anatomy of appendicitis. Am Surg 1994; 60: 68–71.
432. Andreou P, Blain S, Du Boulay CE. A histopathologic study of the appendix at autopsy and after surgical resection. Histopathology 1990; 17: 427–431.
433. Dhillon AP, Williams RA, Rode J. Age, site and distribution of subepithelial neurosecretory cell in the appendix. Pathology 1992; 24: 56–59.
434. Trollope ML, Lindenauer SM. Diverticulosis of the appendix: a collective review. Dis Colon Rectum 1974; 17: 200–218.
435. Lipton S, Estrin J, Glasser I. Diverticular disease of the appendix. Surg Gyn Obstet 1989; 168: 13–16.
436. George DH. Diverticulosis of the vermiform appendix in patients with cystic fibrosis. Hum Pathol 1987; 18: 75–79.
437. McSwain B. Intussusception of the appendix. Review of the literature and report of a case. South Med J 1941; 34: 263–271.
438. McIntosh JC, Mroczek EC, Baldwin C, Mestre J. Intussusception of the appendix in a patient with cystic fibrosis. J Pediatr Gastroenterol Nutr 1990; 11: 542–544.
439. Aubock L, Ratzenhofer M. ‘Extraepithelial enterochromaffin cell-nerve fibre complexes’ in the normal human appendix and in neurogenic appendicopathy. J Pathol 1982; 136: 217–226.
440. Olsen BS, Holck S. Neurogenous hyperplasia leading to appendiceal obliteration: an immunohistochemical study of 237 cases. Histopathology 1987; 11: 843–849.
441. Stanley MW, Cherwitz D, Hagen K, Snover DC. Neuromas of the appendix. A light microscopic, immunohistochemical and electron-microscopic study of 20 cases. Am J Surg Pathol 1986; 10: 801–815.
442. Xiong S, Puri P, Nemeth L, O’Briain DS, Reen DJ. Neuronal hyperplasia in acute appendicitis. Arch Pathol Lab Med 2000; 124: 1429–1433.
443. Shelton T, McKinlay R, Schwartz RW. Acute appendicitis: current diagnosis and treatment. Curr Surg 2003; 60: 502–505.
444. Carr NJ. The pathology of acute appendicitis. Ann Diag Pathol 2000; 4: 46–58.
445. Andersson REB. Meta-analysis of the clinical and laboratory diagnosis of appendicitis. Br J Surg 2004; 91: 28–37.
446. Flum D, Koepsell T. The clinical and economic correlates of misdiagnosed appendicitis: nationwide analysis. Arch Surg 2002; 137: 799–804.
447. McBurney C. Experience with early operative interference in cases of disease of the vermiform appendix. NY Med J 1889; 50: 676–684.
448. Larner AJ. The aetiology of appendicitis. Br J Hosp Med 1988; 39: 540–542.
449. Arnbjornsson E, Bengmark S. Obstruction of the appendix lumen in relation to pathogenesis of acute appendicitis. Acta Chir Scand 1983; 149: 789–791.
450. Arnbjornsson E, Bengmark S. Role of obstruction in the pathogenesis of acute appendicitis. Am J Surg 1984; 147: 390–392.
451. Pieper R, Kager L, Tidefeldt U. Obstruction of the appendix vermiformis causing acute appendicitis: an experimental study in the rabbit. Acta Chir Scand 1982; 148: 63–72.
452. Soffer D, Zait S, Klausner J, Kluger Y. Peritoneal cultures and antibiotic treatment in patients with perforated appendicitis. Eur J Surg 2001; 167: 214–216.
453. Chang AR. An analysis of the pathology of 3003 appendices. Aust NZ J Surg 1981; 51: 169–178.
454. Dymock ZRB. Pathologic changes in the appendix: a review of 1000 cases. Pathology 1977; 9: 331–339.
455. Ahmed MJ. Incidental acute focal appendicitis in incidentally removed vermiform appendices. W V Med J 1966; 62: 151–154.
456. Butler C. Surgical pathology of acute appendicitis. Hum Pathol 1981; 12: 870–878.
457. Sisson RG, Ahlvin RC, Harlow MC. Superficial mucosal ulceration and the pathogenesis of acute appendicitis. Am J Surg 1971; 122: 378–380.
458. Mukherjee A, Schlenker E, LaMasters T, et al. Periappendicitis: is it a clinical entity? Am Surg 2002; 913: 16.
459. Velanovich V, Harkabus MA, Tapia FV, Gusz JR, Vallance SR. When it’s not appendicitis. Am Surg 1998; 64: 7–12.
460. Paik S-Y, Oh JT, Choi YJ, Kwon KW, Yang WI. Measles-related appendicitis. Differing histologic findings according to the stage. Arch Pathol Lab Med 2002; 126: 82–84.
461. Puylaert JB, Van der Zant FM, Mutsaers JA. Infectious ileocecitis caused by Yersinia, Campylobacter, and Salmonella: clinical, radiological and US findings. Eur Radiol 1997; 7: 3–9.
462. Van Noyen R, Selderslaghs R, Bekaert J, Wauters G, Vandepitte J. Causative role of Yersinia and other enteric pathogens in the appendicular syndrome. Eur J Clin Microbiol Infect Dis 1991; 10: 735–741.
463. van Spreeuwel JP, Lindeman J, Bax R, et al. Campylobacter-associated appendicitis: prevalence and clinicopathologic features. Pathol Annu 1987; 22: 55–65.
464. Naktin J, Beavis KG. Yersinea enterocolitica and Yersinea pseudotuberculosis. Clin Lab Med 1999; 19: 523–536.
465. Shorter NA, Thompson MD, Mooney DP, Modlin JF. Surgical aspects of an outbreak of Yersinia enterocolitis. Pediatr Surg Intern 1998; 13: 2–5.
466. Budd JS, Armstrong C. Role of Enterobius vermicularis in the aetiology of appendicitis. Br J Surg 1987; 74: 748–749.
467. Sinniah B, Leopairut J, Neafie RC, Connor DH, Voge M. Enterobiasis: a histopathological study of 259 patients. Ann Trop Med Parasitol 1991; 85: 625–635.
468. William DJ, Dixon M. Enterobius vermicularis and the appendix. Br J Surg 1988; 75: 1225–1226.
469. Gotohda N, Itano S, Okada Y, et al. Acute appendicitis caused by amebiasis. J Gastroenterol 2000; 35: 861–863.
470. Ojo OS, Udeh SC, Odesanmi WO. Review of the histopathological findings in appendices removed for acute appendicitis in Nigerians. J R Coll Surg Edinburgh 1991; 36: 245–248.
471. Graf NS, Arbuckle S. Melanosis of the appendix: common in the paediatric age group. Histopathology 2001; 39: 243–249.
472. Suster S, Moran CA. Deciduosis of the appendix. Am J Gastroenterol 1990; 85: 841–845.
473. Cameron IC, Rogers S, Collins MC, Reed MW. Intestinal endometriosis: presentation, investigation, and surgical management. Int J Colorectal Dis 1995; 10: 83–86.
474. Shwachman H, Holsclaw D. Examination of the appendix at laparotomy as a diagnostic clue in cystic fibrosis. N Engl J Med 1972; 286: 1300–1301.
475. Murthy MS. Appendix in adult mucoviscidosis. N Engl J Med 1972; 287: 411–412.
476. Moyana TN. Necrotizing arteritis of the vermiform appendix. A clinicopathologic study of 12 cases. Arch Pathol Lab Med 1988; 112: 738–741.